Annual ROE:
-93.55%+196.59%(+67.76%)Summary
- As of today, APLS annual return on equity is -93.55%, with the most recent change of +196.59% (+67.76%) on December 31, 2024.
- During the last 3 years, APLS annual ROE has risen by +276.65% (+74.73%).
- APLS annual ROE is now -58.40% below its all-time high of -59.06%, reached on December 31, 2017.
Performance
APLS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-108.60%-12.26%(-12.73%)Summary
- As of today, APLS quarterly return on equity is -108.60%, with the most recent change of -12.26% (-12.73%) on June 30, 2025.
- Over the past year, APLS quarterly ROE has increased by +19.12% (+14.97%).
- APLS quarterly ROE is now -202.84% below its all-time high of -35.86%, reached on June 30, 2015.
Performance
APLS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
APLS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +67.8% | +15.0% |
| 3Y3 Years | +74.7% | +72.9% |
| 5Y5 Years | +70.0% | +62.0% |
APLS ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +74.7% | -30.8% | +57.3% |
| 5Y | 5-Year | at high | +74.7% | -30.8% | +93.2% |
| All-Time | All-Time | -58.4% | +74.7% | -202.8% | +93.2% |
APLS ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -108.60%(-12.7%) |
| Mar 2025 | - | -96.34%(-16.0%) |
| Dec 2024 | -93.55%(+67.8%) | -83.06%(+20.6%) |
| Sep 2024 | - | -104.65%(+18.1%) |
| Jun 2024 | - | -127.72%(+11.2%) |
| Mar 2024 | - | -143.79%(+26.3%) |
| Dec 2023 | -290.14%(+18.0%) | -195.18%(+5.5%) |
| Sep 2023 | - | -206.55%(+1.3%) |
| Jun 2023 | - | -209.36%(-2.2%) |
| Mar 2023 | - | -204.92%(+7.5%) |
| Dec 2022 | -353.93%(+4.4%) | -221.44%(+13.0%) |
| Sep 2022 | - | -254.58%(+36.5%) |
| Jun 2022 | - | -400.77%(+41.3%) |
| Mar 2022 | - | -682.87%(+53.1%) |
| Dec 2021 | -370.20%(-28.2%) | -1457.39%(+8.5%) |
| Sep 2021 | - | -1593.25%(-213.3%) |
| Jun 2021 | - | -508.46%(-141.2%) |
| Mar 2021 | - | -210.82%(-2.2%) |
| Dec 2020 | -288.86% | -206.34%(+40.7%) |
| Sep 2020 | - | -347.97%(-21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -285.51%(-10.3%) |
| Mar 2020 | - | -258.96%(-22.1%) |
| Dec 2019 | -312.20%(-279.4%) | -212.01%(-63.8%) |
| Sep 2019 | - | -129.47%(-29.7%) |
| Jun 2019 | - | -99.80%(-20.4%) |
| Mar 2019 | - | -82.91%(-12.8%) |
| Dec 2018 | -82.28%(-39.3%) | -73.50%(+3.4%) |
| Sep 2018 | - | -76.06%(-16.4%) |
| Jun 2018 | - | -65.34%(+19.4%) |
| Mar 2018 | - | -81.09%(+1.9%) |
| Dec 2017 | -59.06%(+36.0%) | -82.65%(+58.0%) |
| Sep 2017 | - | -196.85%(-34.4%) |
| Jun 2017 | - | -146.48%(-52.3%) |
| Mar 2017 | - | -96.16%(-65.4%) |
| Dec 2016 | -92.31%(+52.2%) | -58.13%(-31.8%) |
| Sep 2016 | - | -44.10%(+77.0%) |
| Dec 2015 | -193.01%(-58.8%) | -191.88%(+24.8%) |
| Sep 2015 | - | -255.00%(-611.1%) |
| Jun 2015 | - | -35.86%(+8.1%) |
| Dec 2014 | -121.58%(-38.8%) | -39.01% |
| Dec 2013 | -87.60% | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of APLS is -93.55%
What is the all-time high annual ROE for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual return on equity is -59.06%
What is Apellis Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, APLS annual return on equity has changed by +196.59% (+67.76%)
What is Apellis Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of APLS is -108.60%
What is the all-time high quarterly ROE for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly return on equity is -35.86%
What is Apellis Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, APLS quarterly return on equity has changed by +19.12% (+14.97%)